<DOC>
	<DOCNO>NCT01044264</DOCNO>
	<brief_summary>A randomized , double-blind , multiple-site , placebo-controlled , parallel-group clinical study conduct evaluate bioequivalence two 1 % Clindamycin/5 % Benzoyl Peroxide Topical Gel formulation .</brief_summary>
	<brief_title>Clinical Study Between Two 1 % Clindamycin/5 % Benzoyl Peroxide Topical Gel Formulations</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Clindamycin palmitate</mesh_term>
	<mesh_term>Clindamycin phosphate</mesh_term>
	<mesh_term>Benzoyl Peroxide</mesh_term>
	<criteria>healthy men woman , 12 year age old willing participate sign copy inform consent form moderate severe facial acne history allergy hypersensitivity clindamycin benzoyl peroxide pregnant lactate woman evidence clinically significant disorder receipt drug part research study within 30 day prior study dose use systemic , topical facial product may interfere study significant facial hair , tattoo , excessive facial scarring , active facial sunburn , peel due sunburn</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Acne Vulgaris</keyword>
	<keyword>bioequivalency</keyword>
	<keyword>clindamycin</keyword>
	<keyword>benzoyl peroxide</keyword>
</DOC>